Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: A double-blind trial

1 UK-37248 (dazoxiben), an orally active thromboxane synthetase inhibitor, was evaluated in a double-blind trial of patients with severe Raynaud's syndrome. 2 Twenty patients were enrolled in the study. Eleven of these patients received dazoxiben 400 mg day and nine received matching placebo ca...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Belch, J. J. F., Cormie, J., Newman, P., McLaren, M., Barbenel, J., Capell, H., Leiberman, P., Forbes, C. D., Prentice, C. R. M.
Formáid: Artigo
Teanga:Inglês
Foilsithe: 1983
Ábhair:
Articles
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1427695/
https://ncbi.nlm.nih.gov/pubmed/6337601
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla